{"corpus_id":210072168,"paper_sha":"837baf0aec2bb43e351ddcb8196e48f648964775","doi":"10.3389/fendo.2019.00888","arxiv_id":null,"pmid":31998229,"pmcid":"6962138","mag_id":3000371909,"dblp_id":null,"acl_id":null,"title":"Hypothyroidism: Cardiovascular Endpoints of Thyroid Hormone Replacement","year":2020,"publication_date":"2020-01-09","venue":"Frontiers in Endocrinology","journal":{"name":"Frontiers in Endocrinology","pages":null,"volume":"10"},"journal_issn":null,"journal_title":null,"publication_types":["Review","JournalArticle"],"pubmed_pub_types":["Journal Article","Review"],"s2_fields_of_study":["Medicine"],"reference_count":94,"citation_count":24,"influential_citation_count":0,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":null,"chemicals":null,"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://www.frontiersin.org/articles/10.3389/fendo.2019.00888/pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/837baf0aec2bb43e351ddcb8196e48f648964775","s2_open_access_license":"CCBY","s2_open_access_status":"GOLD","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Thyroid dysfunction, either thyrotoxicosis or hypothyroidism, represents an important cardiovascular risk factor. Heart disease is the leading cause of death for men and women in the United States. Cardiovascular disease is multifactorial and many efforts have been made to assess precipitants for optimal guideline-based, primary, and secondary prevention. Thyroid hormone receptors are present in the myocardium and endothelium, and small alterations in its levels could have significant effects in cardiac function. Specifically, overt hypothyroidism is associated with an increased risk for atherosclerotic cardiovascular disease due to metabolic and hemodynamic effects. Several concomitant factors like impaired lipid profile, low-grade chronic inflammatory state, increased oxidative stress and increased insulin resistance enforce this relationship. The last decade has seen a renewed interest on the impact of subclinical hypothyroidism on the cardiovascular system and whether or not it should be treated. The aim of this review is to provide current evidence of the effect of thyroid hormone replacement, either with levothyroxine mono-therapy or in combination with liothyronine, on specific cardiovascular parameters.","claims":[{"public_id":"cl_5232541a7e38b057baa5f1d381469134","status":"active","text":"Overt hypothyroidism is associated with an increased risk for atherosclerotic cardiovascular disease due to metabolic and hemodynamic effects.","confidence":0.9,"contributors":[{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["extraction"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/claims/cl_5232541a7e38b057baa5f1d381469134"},{"public_id":"cl_4ab94fba559c665aba39e3708f0eeb9a","status":"active","text":"Several concomitant factors like impaired lipid profile, low-grade chronic inflammatory state, increased oxidative stress and increased insulin resistance enforce the relationship between hypothyroidism and cardiovascular disease.","confidence":0.85,"contributors":[{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["extraction"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/claims/cl_4ab94fba559c665aba39e3708f0eeb9a"}],"concepts":[{"public_id":"co_002f1ed204c5d4cdb50daee97d10638e","status":"active","name":"overt hypothyroidism","description":"A form of thyroid dysfunction with clearly elevated TSH and low free thyroid hormones, associated with increased cardiovascular risk.","types":["condition"],"aliases":[],"contributors":[{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["extraction"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_002f1ed204c5d4cdb50daee97d10638e"},{"public_id":"co_0b8da357087816f8abd747a678c1d85f","status":"active","name":"cardiovascular parameters","description":"Specific measures of cardiovascular function or risk that are affected by thyroid hormone replacement.","types":["outcome"],"aliases":[],"contributors":[{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["extraction"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_0b8da357087816f8abd747a678c1d85f"},{"public_id":"co_1e28e4cd02a002aef305f9ff5cfc65f5","status":"active","name":"levothyroxine mono-therapy","description":"Treatment of hypothyroidism using levothyroxine alone, without combination with liothyronine.","types":["therapeutic approach"],"aliases":[],"contributors":[{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["extraction"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_1e28e4cd02a002aef305f9ff5cfc65f5"},{"public_id":"co_438e726d6c6433ac55fafb4381b0c908","status":"active","name":"increased oxidative stress","description":"Elevated levels of reactive oxygen species that contribute to cardiovascular damage in hypothyroidism.","types":["risk factor"],"aliases":[],"contributors":[{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["extraction"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_438e726d6c6433ac55fafb4381b0c908"},{"public_id":"co_70eb4fb028855187b727b72efae50c67","status":"active","name":"low-grade chronic inflammatory state","description":"Persistent mild inflammation that enforces the link between hypothyroidism and cardiovascular disease.","types":["risk factor"],"aliases":[],"contributors":[{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["extraction"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_70eb4fb028855187b727b72efae50c67"},{"public_id":"co_957751446aa7c882b85807110ccc0d11","status":"active","name":"thyroid hormone replacement","description":"Therapeutic administration of thyroid hormones to treat hypothyroidism, including levothyroxine and liothyronine.","types":["therapeutic approach"],"aliases":[],"contributors":[{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["extraction"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_957751446aa7c882b85807110ccc0d11"},{"public_id":"co_ba9bcaaadaea0d8d2dc0a7165c931863","status":"active","name":"increased insulin resistance","description":"Reduced sensitivity to insulin that enforces the relationship between hypothyroidism and cardiovascular disease.","types":["risk factor"],"aliases":[],"contributors":[{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["extraction"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_ba9bcaaadaea0d8d2dc0a7165c931863"},{"public_id":"co_d613f53c10dd99de11988efb007483a3","status":"active","name":"atherosclerotic cardiovascular disease","description":"Cardiovascular disease driven by atherosclerosis, for which overt hypothyroidism increases risk.","types":["condition"],"aliases":[],"contributors":[{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["extraction"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_d613f53c10dd99de11988efb007483a3"},{"public_id":"co_f31a6fbc49a23327ad2a51eb79fd30ec","status":"active","name":"impaired lipid profile","description":"Abnormal blood lipid levels that contribute to cardiovascular risk in hypothyroidism.","types":["risk factor"],"aliases":[],"contributors":[{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["extraction"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_f31a6fbc49a23327ad2a51eb79fd30ec"},{"public_id":"co_f81105ce0f65cf74ac38bbe1d7b3ce15","status":"active","name":"liothyronine","description":"The active thyroid hormone T3, used in combination therapy with levothyroxine for thyroid hormone replacement.","types":["drug"],"aliases":[],"contributors":[{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["extraction"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_f81105ce0f65cf74ac38bbe1d7b3ce15"}],"external_ids":{"DOI":"10.3389/fendo.2019.00888","ArXiv":null,"PubMed":31998229,"PubMedCentral":"6962138","MAG":3000371909,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://www.frontiersin.org/articles/10.3389/fendo.2019.00888/pdf","landing_url":"https://www.semanticscholar.org/paper/837baf0aec2bb43e351ddcb8196e48f648964775","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBY","status":"GOLD","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":633156,"paper_uid":"dcece4fb-ab55-42ba-8627-64615de748e5","canonical_identity":{"paper_id":633156,"paper_uid":"dcece4fb-ab55-42ba-8627-64615de748e5","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/210072168"}